BioPharma

Hemispherx Losses Stable $HEB $XHS

Hemispherx Biopharma., has announced its for the first quarter of FY-2015. The results shows EPS remains stable -$0.02 YoY, whereas cash and cash Assets were improved from $16.108 Million to $17.005 Million YoY. View the full earnings release here.